CHARLES J. CASAMENTO

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

GT Biopharma, Inc.

Filing Date Source Excerpt
2023-05-01 Charles J. Casamento.
2023-11-06 Charles J. Casamento (3) Consists of options to purchase 291,666 shares of common stock.
2024-04-29 Mr. Casamento was appointed to our Board of Directors on May 1, 2023. Mr. Casamento is currently executive director and principal of The Sage Group, a healthcare advisory group specializing in mergers, acquisitions, and partnerships between biotechnology companies and pharmaceutical companies.

Data sourced from SEC filings. Last updated: 2025-08-30